FDA Clears Greystone's Epi-Max for Sale in the U.S.

May 20, 2005

Greystone Medical announced that it has received FDA clearance to market and sell Epi-Max, a wound care product created for the treatment of diabetic skin ulcers and other conditions. The FDA cleared Epi-Max as a combination product, one of the few advanced wound care products that contains both a drug and a device.

()a href="http://www.primezone.com/newsroom/?d=78457" target="_blank">PrimeZone